Albireo Pharma, Inc. (ALBO) Financials

NASDAQ Currency in USD Disclaimer

$44.15

north_east NA Past Year
Day's range
$44
Day's range
$44.9
$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200MEarning201520152016201620172017201820182019201920202020202120210%0%-500000%-500000%-1000000%-1000000%-1500000%-1500000%-2000000%-2000000%-2500000%-2500000%Profit Margin
Profit Margin
Revenue
Earnings

ALBO Income statement / Annual

Last year (2021), Albireo Pharma, Inc.'s total revenue was $40.58 M, an increase of 388.43% from the previous year. In 2021, Albireo Pharma, Inc.'s net income was -$151.35 M. See Albireo Pharma, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 09/30/2015 09/30/2014 09/30/2013 09/30/2012
Operating Revenue $40.58 M $8.31 M $9.64 M $12.74 M $1,000.00 $11.36 M $0.00 $0.00 $0.00 $0.00
Cost of Revenue $1.36 M $0.00 $2.21 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $39.22 M $8.31 M $7.43 M $12.74 M $1,000.00 $11.36 M $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.97 1 0.77 1 1 1 0 0 0 0
Research and Development Expenses $82.52 M $76.78 M $45.58 M $31.73 M $12.99 M $8.08 M $13.37 M $14.19 M $14.30 M $12.57 M
General & Administrative Expenses $0.00 $42.45 M $22.96 M $18.06 M $15.25 M $15.79 M $6.40 M $5.60 M $6.84 M $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $69.57 M $42.45 M $22.96 M $18.06 M $15.25 M $15.79 M $6.40 M $5.60 M $6.84 M $6.82 M
Other Expenses $10.62 M -$14.65 M $2.21 M $837,000.00 -$3.66 M -$2.68 M $0.00 $0.00 $0.00 $0.00
Operating Expenses $162.71 M $104.58 M $70.75 M $50.63 M $24.58 M $23.66 M $19.77 M $19.26 M $20.59 M $19.30 M
Cost And Expenses $164.06 M $104.58 M $70.75 M $50.63 M $24.58 M $23.66 M $19.77 M $19.26 M $20.59 M $19.30 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $52,000.00 $49,000.00 $56,000.00 $80,000.00
Interest Expense $13.93 M $11.36 M $5.30 M $0.00 $40,000.00 $1.32 M $52,000.00 $49,000.00 $0.00 $0.00
Depreciation & Amortization $103.66 M $192,000.00 $3.82 M $45,000.00 $35,000.00 $14,000.00 $197,000.00 $603,000.00 $641,000.00 $725,000.00
EBITDA -$122.13 M $0.00 -$57.29 M -$50.88 M -$24.13 M -$14.96 M -$20.58 M -$23.77 M $0.00 $0.00
EBITDA Ratio -0.49 -11.56 -5.95 -2.97 -24542 -1.32 0 0 0 0
Operating Income Ratio -3.04 -11.59 -6.34 -2.97 -24577 -1.08 0 0 0 0
Total Other Income/Expenses Net $89.46 M -$11.36 M -$1.61 M -$8.20 M $375,000.00 -$3.99 M $2.07 M $10.26 M $1.22 M -$1.43 M
Income Before Tax -$34.03 M -$107.63 M -$62.72 M -$46.09 M -$24.20 M -$16.29 M -$18.71 M -$14.11 M -$19.32 M -$20.73 M
Income Before Tax Ratio -0.84 -12.96 -6.51 -3.62 -24202 -1.43 0 0 0 0
Income Tax Expense $117.32 M $11.36 M $8.99 M $20,000.00 $212,000.00 $62,000.00 $29,000.00 $26,000.00 $15,000.00 $18,000.00
Net Income -$151.35 M -$119.00 M -$71.70 M -$46.11 M -$24.41 M -$16.35 M -$18.74 M -$14.13 M -$19.34 M -$20.75 M
Net Income Ratio -3.73 -14.32 -7.44 -3.62 -24414 -1.44 0 0 0 0
EPS -7.87 -7.45 -5.77 -3.94 -3.12 -13.19 -13.7 -19.81 -37.06 -57.19
EPS Diluted -7.87 -7.45 -5.77 -3.94 -3.12 -13.19 -13.7 -19.81 -37.06 -57.19
Weighted Average Shares Out $19.22 M $15.98 M $12.44 M $11.70 M $7.82 M $1.24 M $1.37 M $713,468.00 $521,679.00 $362,752.00
Weighted Average Shares Out Diluted $19.22 M $15.98 M $12.44 M $11.70 M $7.82 M $1.24 M $1.37 M $713,468.00 $521,679.00 $362,752.00
Link